Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aubio Life Sciences is a biotechnology company focused on developing skin care products and topical treatments derived from proprietary botanical extracts. The company's primary product is the Aubio Cold Sore Gel, which utilizes a unique extract from the carnivorous Sarracenia purpurea (Purple Pitcher Plant) to treat and manage symptoms of Herpes Labialis. Backed by billionaire entrepreneur John Paul DeJoria, the company emphasizes the use of natural plant-based defenses to address viral skin conditions. Aubio's research and development efforts are centered on the antiviral and skin-rejuvenating properties of their unique botanical discoveries, aiming to provide effective over-the-counter alternatives to synthetic medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aubio Life Sciences.